Search results for "Statins"
Self-administered aspirin immediately after myocardial infarction saves lives, study finds
Taking aspirin within four hours of severe chest pain onset and continuing treatment for 28 days after an acute myocardial infarction delayed 13,016 deaths annually, even after accounting for 963 deaths due to bleeding, researchers estimated.
https://immattersacp.org/weekly/archives/2024/05/07/4.htm
7 May 2024
Take a team approach to coronary disease
A major update to a cardiology guideline puts team-based, patient-centered care at the forefront of management and highlights the role of healthy diet and exercise habits in reducing cardiovascular risk.
https://immattersacp.org/archives/2024/02/take-a-team-approach-to-coronary-disease.htm
1 Feb 2024
EHR alert had small effect on lipid therapy in highest-risk patients
A trial alert nudged clinicians seeing patients with very high-risk atherosclerotic cardiovascular disease to intensify therapy by prescribing a high-intensity statin, adding ezetimibe, or prescribing a proprotein subtilisin/kexin type 9 inhibitor.
https://immattersacp.org/weekly/archives/2024/04/30/4.htm
30 Apr 2024
Recommendations released on statin therapy for people with HIV
The guidance from a panel of the U.S. Department of Health and Human Services addresses primary prevention of atherosclerotic cardiovascular disease in patients ages 40 to 75 years and younger than age 40 years.
https://immattersacp.org/weekly/archives/2024/03/05/2.htm
5 Mar 2024
Latest updates on ACP's priorities, initiatives
ACP Spotlight offers readers a look at ACP's current top priorities and initiatives, as well as highlights from our e-newsletter, I.M. Matters Weekly from ACP.
https://immattersacp.org/archives/2024/01/latest-updates-on-acps-priorities-initiatives.htm
1 Jan 2024
U.S. statin use plateaued in 2013 to 2018
Most U.S. adults with the strongest guideline recommendations for primary prevention with statins are not receiving them, including those with diabetes, extremely high cholesterol levels, or 10-year risk of cardiovascular disease over 20%, a study found.
https://immattersacp.org/weekly/archives/2023/12/05/1.htm
5 Dec 2023
Statins underused in patients with cardiovascular disease, study finds
Women, older adults, and those with peripheral artery disease and cerebrovascular disease are particularly likely not to receive statins, according to an industry-funded analysis of lipid-lowering therapy use.
https://immattersacp.org/weekly/archives/2023/08/08/2.htm
8 Aug 2023
Statins rarely cause muscle pain, meta-analysis finds
Statin therapy caused approximately 11 reports of any muscle pain or weakness per 1,000 treated patients during the first year of use, but little after, according to an analysis of placebo-controlled trials and trials of more intensive versus less intensive statin therapy.
https://immattersacp.org/weekly/archives/2022/09/06/4.htm
6 Sep 2022
Statins not associated with memory or cognition decline in elderly
Statins were associated with preserved cognitive ability in some subgroups, and the study may offer reassurance to patients concerned about statins' effects on the brain, study authors wrote.
https://immattersacp.org/weekly/archives/2019/11/19/4.htm
19 Nov 2019
Study finds no difference in muscle symptom scores between statin, placebo
Three months after 200 primary care patients in the U.K. who previously reported muscle symptoms from statins underwent a series of randomized, placebo-controlled, n-of-one trials, about two-thirds said they planned to restart statin treatment.
https://immattersacp.org/weekly/archives/2021/03/02/2.htm
2 Mar 2021